Evidence map›Paper›PMID 40388579›Full record

ReviewThyroid : official journal of the American Thyroid Association2025

Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a Cure.

Maria E Cabanillas, Neal Akhave, Victoria Banuchi, Naifa Busaidy, Ramona Dadu, Renata Ferrarotto, Gary B Gunn, Sarah Hamidi, Marie-Claude Hofmann, S Mohsen Hosseini and 9 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Thyroid : official journal of the American Thyroid Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Maria E CabanillasThe Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-5124-1811
Neal AkhaveThoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Victoria BanuchiHead and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Naifa BusaidyThe Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ramona DaduThe Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Renata FerrarottoThoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gary B GunnRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sarah HamidiThe Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Marie-Claude HofmannThe Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
S Mohsen HosseiniPathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Priyanka C IyerThe Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stephen Y LaiHead and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anna LeeRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anastasios ManiakasRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matthew S NingThoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michael SpiottoRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jennifer R WangHead and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michelle D WilliamsPathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mark ZafereoHead and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsHumansImmunotherapyMolecular Targeted TherapyMutationProto-Oncogene Proteins B-rafBRAF protein, humanProto-Oncogene Proteins B-rafBRAF mutationchemotherapyimmunotherapyPDL1radiationRAS mutation

Identifiers

PMID40388579
PMCPMC12491964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.